L-Type Calcium Channels Rescues Dilated Cardiomyopathy 10/02/25

Welcome to Cardiology Today – Recorded October 02, 2025. This episode summarizes 5 key cardiology studies on topics like Transcatheter aortic valve replacement and Calcium current. Key takeaway: L-Type Calcium Channels Rescues Dilated Cardiomyopathy. Article Links: Article 1: PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement – A multicenter retrospective registry analysis. (International journal of cardiology) Article 2: Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit. (International journal of cardiology) Article 3: Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry. (International journal of cardiology) Article 4: Evaluating cardiovascular risk factors in breast cancer survivors: The role of echocardiography and cardiopulmonary exercise testing in the Munich Cardio-Oncology-Exercise retrospective Registry. (International journal of cardiology) Article 5: RRAD-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failure. (Cardiovascular research) Full episode page: https://podcast.explainheart.com/podcast/l-type-calcium-channels-rescues-dilated-cardiomyopathy-10-02-25/ Featured Articles Article 1: PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement – A multicenter retrospective registry analysis. Journal: International journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40446851 Summary: in A.C.U.R.A.T.E. neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement – A multicenter retrospective registry analysis. This multicenter retrospective registry analyzed predictors of paravalvular leak (P.V.L.) following implantation of the A.C.U.R.A.T.E. neo2 self-expanding aortic valve prosthesis during transcatheter aortic valve replacement (T.A.V.R.). The study evaluated if dedicated implantation techniques could further reduce P.V.L., a known complication the valve’s extended sealing skirt aims to mitigate. Such findings are critical for optimizing T.A.V.R. procedures and improving patient outcomes by minimizing post-procedural regurgitation. Article 2: Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit. Journal: International journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40446850 Summary: This prospective, single-center cohort study evaluated the performance of four established scoring systems for predicting 90-day mortality in patients admitted to a contemporary Cardiac Intensive Care Unit (C.I.C.U.). Researchers compared the Acute Physiology and Chronic Health Evaluation (A.P.A.C.H.E.), Sequential Organ Failure Assessment (S.O.F.A.), Mayo C.I.C.U. Admission Risk Score (M.C.A.R.S.), and Clinical Frailty Scale (C.F.S.) scores in an unselected C.I.C.U. population. The findings identified which scoring systems offer superior predictive accuracy, thereby providing critical guidance for risk stratification and clinical decision-making in this high-risk patient group. Article 3: Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry. Journal: International journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40441608 Summary: This study conducted an external validation of MitraScore, a novel tool developed for predicting mortality risk in patients undergoing mitral transcatheter edge-to-edge repair (M-T.E.E.R.). Using data from the O.C.E.A.N.-Mitral registry, researchers assessed MitraScore’s performance across diverse mitral regurgitation (M.R.) subtypes, extending beyond its initial derivation in functional M.R. The validation confirmed the score’s accuracy in identifying patients at higher mortality risk, thereby enhancing patient stratification and selection for M-T.E.E.R. across a broader spectrum of M.R. etiologies. Article 4: Evaluating cardiovascular risk factors in breast cancer survivors: The role of echocardiography and cardiopulmonary exercise testing in the Munich Cardio-Oncology-Exercise retrospective Registry. Journal: International journal of cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40425074 Summary: This retrospective, single-center study investigated cardiovascular disease risk factors (C.V.D.R.F.) in breast cancer survivors (B.C.S.) previously treated with either anthracycline/H.E.R.2-targeted therapy (A.C./H.) or endocrine therapy (E.T.). The research utilized echocardiography and cardiopulmonary exercise testing (C.P.E.T.) to assess cardiac function and fitness. The findings elucidated the differential impact of treatment regimens and the utility of these diagnostic tools in identifying B.C.S. at elevated C.V.D. risk, thereby informing tailored cardio-oncology surveillance strategies. Article 5: RRAD-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failure. Journal: Cardiovascular research PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41032675 Summary: This study investigated the therapeutic potential of targeting L-type calcium channel (L.T.C.C.) regulation for heart failure, specifically challenging the dogma that enhanced trigger calcium (Ca2+) is always maladaptive. Researchers utilized myocardial R.R.A.D. knockout (c.R.A.D.Δ/Δ) mice, which exhibit a tonically modulated L.T.C.C. current (I.Ca,L) that preserves healthy myocardium. The findings demonstrated that this modulated I.Ca,L can effectively rescue dilated cardiomyopathy, revealing a promising new strategy for treating Heart Failure with Reduced Ejection Fraction (H.F.r.E.F.) by fine-tuning L.T.C.C. activity. Transcript Today’s date is October 02, 2025. Welcome to Cardiology Today. Here are the latest research findings. Article number one. P.V.L. in A.C.U.R.A.T.E. neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement – A multicenter retrospective registry analysis. This multicenter retrospective registry analyzed predictors of paravalvular leak (P.V.L.) following implantation of the A.C.U.R.A.T.E. neo2 self-expanding aortic valve prosthesis during transcatheter aortic valve replacement (T.A.V.R.). The study evaluated if dedicated implantation techniques could further reduce P.V.L., a known complication the valve’s extended sealing skirt aims to mitigate. Such findings are critical for optimizing T.A.V.R. procedures and improving patient outcomes by minimizing post-procedural regurgitation. Article number two. Performance evaluation of four scoring systems for mortality prediction in a contemporary cardiac intensive care unit. This prospective, single-center cohort study evaluated the performance of four established scoring systems for predicting 90-day mortality in patients admitted to a contemporary Cardiac Intensive Care Unit (C.I.C.U.). Researchers compared the Acute Physiology and Chronic Health Evaluation (A.P.A.C.H.E.), Sequential Organ Failure Assessment (S.O.F.A.), Mayo C.I.C.U. Admission Risk Score (M.C.A.R.S.), and Clinical Frailty Scale (C.F.S.) scores in an unselected C.I.C.U. population. The findings identified which scoring systems offer superior predictive accuracy, thereby providing critical guidance for risk stratification and clinical decision-making in this high-risk patient group. Article number three. Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the O.C.E.A.N.-mitral registry. This study conducted an external validation of MitraScore, a novel tool developed for predicting mortality risk in patients undergoing mitral transcatheter edge-to-edge repair (M-T.E.E.R.). Using data from the O.C.E.A.N.-Mitral registry, researchers assessed MitraScore’s performance across diverse mitral regurgitation (M.R.) subtypes, extending beyond its initial derivation in functional M.R. The validation confirmed the score’s accuracy in identifying patients at higher mortality risk, thereby enhancing patient stratification and selection for M-T.E.E.R. across a broader spectrum of M.R. etiologies. Article number four. Evaluating cardiovascular risk factors in breast cancer survivors: The role of echocardiography and cardiopulmonary exercise testing in the Munich Cardio-Oncology-Exercise retrospective Registry. This retrospective, single-center study investigated cardiovascular disease risk factors (C.V.D.R.F.) in breast cancer survivors (B.C.S.) previously treated with either anthracycline/H.E.R.2-targeted therapy (A.C./H.) or endocrine therapy (E.T.). The research utilized echocardiography and cardiopulmonary exercise testing (C.P.E.T.) to assess cardiac function and fitness. The findings elucidated the differential impact of treatment regimens and the utility of these diagnostic tools in identifying B.C.S. at elevated C.V.D. risk, thereby informing tailored cardio-oncology surveillance strategies. Article number five. R.R.A.D.-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failure. This study investigated the therapeutic potential of targeting L-type calcium channel (L.T.C.C.) regulation for heart failure, specifically challenging the dogma that enhanced trigger calcium (Ca2+) is always maladaptive. Researchers utilized myocardial R.R.A.D. knockout (c.R.A.D.Δ/Δ) mice, which exhibit a tonically modulated L.T.C.C. current (I.Ca,L) that preserves healthy myocardium. The findings demonstrated that this modulated I.Ca,L can effectively rescue dilated cardiomyopathy, revealing a promising new strategy for treating Heart Failure with Reduced Ejection Fraction (H.F.r.E.F.) by fine-tuning L.T.C.C. activity. Thank you for listening. Don’t forget to subscribe. Keywords Transcatheter aortic valve replacement, Calcium current, Heart Failure with Reduced Ejection Fraction, O.C.E.A.N.-Mitral registry, L-type calcium channel, Endocrine therapy, Paravalvular leak, Echocardiography, Cardio-oncology, H.E.R.2-targeted therapy, Anthracycline, Mitral regurgitation, Mortality risk prediction, Mitral transcatheter edge-to-edge repair, Aortic valve prosthesis, Cardiovascular disease risk factors, Implantation technique, A.P.A.C.H.E. score, Clinical Frailty Scale, Cardiac Intensive Care Unit, MitraScore, Dilated cardiomyopathy, A.C.U.R.A.T.E. neo2, S.O.F.A. score, Therapeutic target, Mortality prediction, Cardiopulmonary exercise testing, R.R.A.D. knockout, Breast cancer survivors, Mayo C.I.C.U. Admission Risk Score. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post L-Type Calcium Channels Rescues Dilated Cardiomyopathy 10/02/25 first appeared on Cardiology Today.